John Libbey Eurotext

Annales de Biologie Clinique


Biological assay for galactose-1 phosphate measurement application in subjects with galactosemia Volume 70, issue 1, Janvier-Février 2012

Département de biochimie, Faculté de médecine, Sousse, Tunisie
  • Key words: congenital galactosemia, galactose-1-phosphate, fluorometric method « spot test »
  • DOI : 10.1684/abc.2011.0653
  • Page(s) : 85-8
  • Published in: 2012

Congenital galactosemia is a hereditary, autosomal recessive and metabolic disease. It is linked to an enzyme deficiency, more commonly known by the deficiency of galactose-1- phosphate uridyltransferase (GALT), which is responsible for an accumulation of galactose-1- phosphate in the blood. Clinical symptoms appear early in infancy from the second week of life. They generally manifested by some disorders within liver, kidney, eye, gastrointestinal, neurological and also with cataracts. Currently, the clinical diagnosis remains difficult hence the importance of further investigations based on effective biological assessments to highlight the disease. The diagnosis of galactosemia is made by the laboratory test. The latter includes the determination of Gal-1-P which is done by a fluorometric method spot test. This study was conducted in order to assess the repeatability, reproducibility, accuracy, and effectiveness of the techniques used. We have found the CV for a repeatability (CV = 5 %), reproducibility (CV = 4 %) which confirms the accuracy of the method proceeded in this study. This method allows us to have a degree of inaccuracy less than 1%. According to the study of the effectiveness of “spot test”, we found that our technique is specific (Sp = 93 %) and sensitive (Se = 83 %).